Evaluation of TurboHawk Plaque Rotation System in Treatment of Superficial Femoral Atherosclerosis

Guan, Sheng; Sun, Jing; Jiareke, Tang; Ge, Xiaohu

doi:10.12659/msm.912142

Cited by 3 publications

(10 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[ 1 , 2 , 5 , 6 ] Previous similar studies suggested THPRS for the treatment of patients with AOLE. [ 27 , 28 ] One study reported THPRS in the treatment of patients with superficial femoral atherosclerosis (SFA). [ 27 ] It retrospectively analyzed 60 patient case records (including 50 males and 10 females) of superficial femoral atherosclerotic stenosis and occlusion treated by THPRS.…”

Section: Discussionmentioning

confidence: 99%

“…[ 27 , 28 ] One study reported THPRS in the treatment of patients with superficial femoral atherosclerosis (SFA). [ 27 ] It retrospectively analyzed 60 patient case records (including 50 males and 10 females) of superficial femoral atherosclerotic stenosis and occlusion treated by THPRS. [ 27 ] Its findings showed that THPRS may be effective for the management of SFA in a short period.…”

Section: Discussionmentioning

confidence: 99%

“…[ 27 ] It retrospectively analyzed 60 patient case records (including 50 males and 10 females) of superficial femoral atherosclerotic stenosis and occlusion treated by THPRS. [ 27 ] Its findings showed that THPRS may be effective for the management of SFA in a short period. In addition, it exerts less trauma and satisfied safety.…”

Section: Discussionmentioning

confidence: 99%

“…In addition, it exerts less trauma and satisfied safety. [ 27 ] The other study appraised the efficacy and safety of directional atherectomy with Silver HawkTM device in the management of in-stent restenosis of femoropopliteal artery. [ 28 ] The results of this study found that atherectomy of in-stent restenosis showed promising initial success rate.…”

Section: Discussionmentioning

confidence: 99%

“…[ 7 , 26 ] However, its long-term patency rate is still not satisfied, [ 7 , 26 ] with 2-year patency rate of 64.2%. [ 7 ] Although TurboHawk plaque rotation system (THPRS) is report to achieve better efficacy in patency rate in patients with AOLE, [ 27 , 28 ] there is still insufficient evidence to support THPRS for AOLE. Thus, this pilot retrospective study assessed the feasible efficacy and complications of THPRS for the treatment of patients with AOLE.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

TurboHawk plaque rotation system for treatment of arteriosclerosis occlusion in lower extremities

Yuan¹,

Yang²,

Wang³

et al. 2021

Medicine

View full text Add to dashboard Cite

This pilot study retrospectively assessed the feasible efficacy of TurboHawk plaque rotation system (THPRS) for treatment of arteriosclerosis occlusion in lower extremities (AOLE). A total of 36 eligible patients with AOLE were included in this pilot retrospective study. We divided all those patients into a treatment group and a control group, each group 18 patients. All patients in both groups administered conventional therapy. Additionally, all patients in the treatment group received THPRS, while all patients in the control group received percutaneous transluminal angioplasty (PTA) and percutaneous transluminal stenting (PTS). All outcomes were evaluated and analyzed at 3-month after surgery. At 3-month postsurgery, there were not significant statistical differences in clinical manifestations (intermittent claudication, P = .49; resting pain, P = .28), ankle brachial index change ( P = .07), 6-minute walk distance ( P = .43), and complications between 2 groups. This pilot study did not show better outcome improvement of THPRS for patients with AOLE. We cautiously draw the present conclusion, because it suffers from several major restrictions. Thus, further studies with larger sample size and longer term follow-up are still needed to warrant the current conclusion.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

TurboHawk plaque rotation system for treatment of arteriosclerosis occlusion in lower extremities

Yuan¹,

Yang²,

Wang³

et al. 2021

Medicine

View full text Add to dashboard Cite

show abstract

Short‐term efficacy and safety of TurboHawk atherectomy for in‐stent restenosis in peripheral artery disease: a single‐centre experience

Qin

Shi

Zhuo

et al. 2022

ANZ Journal of Surgery

View full text Add to dashboard Cite

Background: Information regarding the efficacy of the TurboHawk atherectomy for the treatment of in-stent restenosis (ISR) in patients with peripheral artery disease (PAD) of the lower extremity is scarce. This study was performed to investigate the curative efficacy and safety of the TurboHawk system for ISR in PAD patients over 60 years old. Methods: The TurboHawk atherectomy device was used to treat ISR in 28 patients with PAD. The intraoperative, 2-day postoperative, 3-month, and 2-year follow-up data were obtained. Differences in the ankle-brachial index (ABI), Rutherford class and minimum diameter of the femoral-popliteal artery were analysed along with the correlations of the factors associated with patency. Results: Twenty-six patients (92.86%) had successful surgeries. All patients reported alleviation of pain and intermittent claudication after surgery. One patient who had a malignant hepatoma and coronary heart disease received an amputation on the 76th postoperative day and another patient who had atrial fibrillation received a thrombectomy on the 40th postoperative day. TurboHawk atherectomy increased the ABI (from 0.30 to 0.70, P < 0.0001) and minimum diameter (from 0 to 4.93 mm, P < 0.0001) and reduced the Rutherford class (from 4.00 to 2.00, P < 0.0001). During the 3-month follow-up, the median minimum diameter, ABI, and Rutherford class were 4.12, 0.69, and 2.00, respectively. No death happened during the 3-month follow-up. Conclusions: The TurboHawk atherectomy is a safe and effective technique for ISR in PAD patients over 60 years old. and excisional atherectomy. 4,5 However, data on the efficacy and safety of the TurboHawk plaque excision system for ISR in patients with lower extremity PAD is lacking.This study aimed to evaluate the efficacy and safety of TurboHawk atherectomy in ISR. The ischaemic limbs of 28 patients with ISR were treated by TurboHawk atherectomy. The intraoperative, 2-day and 3-month postoperative data were collected and analysed.

show abstract

Immunometabolic stress and herbal medicines in atherosclerosis

Liang,

Xia,

Cui

2023

Preprint

View full text Add to dashboard Cite

Atherosclerosis is a widespread illness that gravely endangers human health and is the fundamental pathological foundation of many cardiovascular and cerebrovascular diseases. The absorption and storage of oxidatively modified LDL by certain specofoc cells in immune cells, such as macrophages, causes varieties of immunooxidative processes. These processes of stress lead to plaque rupture through inflammatory processes, and then drives the development of atherosclerotic lesions. Now, the medications for the treatment of atherosclerosis are mostly lipid-lowering, anticoagulant, and thrombolytic agents, but the therapeutic outcomes are insufficient. It is determined that traditional Chinese medicine has achieved good clinical efficacy in treating atherosclerotic illnesses. However, the mechanism of TCM therapy for atherosclerosis needs to be elucidated. This paper highlights the target mechanism and structural features of traditional Chinese medicine components and compounds in controlling the connections mentioned above and then regulating atherosclerosis, hoping to propose novel techniques for treating and preventing the disease.

show abstract

Evaluation of TurboHawk Plaque Rotation System in Treatment of Superficial Femoral Atherosclerosis

Cited by 3 publications

References 8 publications

TurboHawk plaque rotation system for treatment of arteriosclerosis occlusion in lower extremities

TurboHawk plaque rotation system for treatment of arteriosclerosis occlusion in lower extremities

Short‐term efficacy and safety of TurboHawk atherectomy for in‐stent restenosis in peripheral artery disease: a single‐centre experience

Immunometabolic stress and herbal medicines in atherosclerosis

Contact Info

Product

Resources

About